AVIR

Atea Pharmaceuticals (AVIR)

About Atea Pharmaceuticals (AVIR)

Atea Pharmaceuticals, Inc. is a clinical stage company, which focuses on discovering, developing, and commercializing antiviral therapeutics. Its product pipelines include Coronaviridae, Flaviviridae, and Paramyxovirdae. The company was founded by Jean-Pierre Sommadossi and David Chu in July 2012 and is headquartered in Boston, MA.

Details

Daily high

$3.40

Daily low

$3.27

Price at open

$3.31

52 Week High

$4.60

52 Week Low

$2.75

Market cap

281.3M

Dividend yield

0.00%

Volume

406,557

Avg. volume

492,753

P/E ratio

-1.61

Atea Pharmaceuticals News